Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001209191-21-038079

Options or other derivatives

  • Director acquired 10,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Svoronos Dawn Director 2021-06-03 Grant or award · Stock Option (Right to Buy) +10,000 10,000 D: show line 1 in the form
Loading xslF345X03/doc4.xml…